Stanford researchers will discuss their agentic 'scientists' that are on course to reshape drug discovery at VB Transform 2026

Drug discovery is notoriously inefficient. Pharmaceutical projects span years, moving from one specialized human team to the next through disconnected workflows that result in knowledge loss during each handoff. A shocking 90% to 95% of drug discovery projects reportedly fail — one of the highest failure rates of any industry. A single successful drug can take over a dozen years and up to $1 billion from initial discovery to patient distribution, according to published reports. Generative AI is being used to solve some of the challenges, but Stanford researchers have moved the ball forward with agentic AI. A team led by James Zou, associate professor of Biomedical Data Science at Stanford University, has deployed thousands autonomous AI "scientist" agents in a virtual biotech that simulates the full lifecycle of drug development. The agents handle everything from initial discovery through safety testing and clinical trial design, while maintaining the continuity that’s lacking in today’s drug discovery processes, according to Zou.The project uses a hierarchical orchestration framework. At the top sits a chief scientist officer agent that acts as a planner, delegating tasks to teams of specialized agents, Zou told VentureBeat during a call ahead of his upcoming session at VB Transform 2026.While one team of agents focuses on discovery, another manages safety, and others handle specialized analytical tasks. Because these agents operate within a unified, hierarchical ecosystem, they retain the full context of a project, maintaining continuity from the first molecule identified to the final clinical outcome.The "brain" of the system relies on a vast amount of primary data. The agents are granted access to data sources ranging from genomics and FDA chemistry data to clinical trial databases using a model context protocol.The team has invested heavily in agent-native and agent-friendly data, allowing the AI to synthesize complex information more effectively. The system re